drugset / Trial / NCT00150306

A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD

NCT00150306

Phase 3 Terminated 160 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety and efficacy of sertraline compared to placebo in children and adolescents (6 to 17 years of age) who are outpatients with Posttraumatic Stress Disorder.

Timeline

Start
2002-11
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 50 mg
Subject Sertraline Small molecule 200 mg